| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 539.857 | 449.148 | 496.491 | 402.547 | 362.171 | 290.997 | 599.476 | 532.743 | 448.739 | 363.144 |
| Total Income - EUR | 571.646 | 419.992 | 531.825 | 427.980 | 368.275 | 369.748 | 571.508 | 548.785 | 459.571 | 372.017 |
| Total Expenses - EUR | 536.684 | 417.352 | 526.008 | 423.239 | 363.676 | 365.845 | 458.969 | 536.593 | 454.505 | 366.270 |
| Gross Profit/Loss - EUR | 34.962 | 2.641 | 5.817 | 4.741 | 4.598 | 3.903 | 112.539 | 12.192 | 5.066 | 5.747 |
| Net Profit/Loss - EUR | 25.611 | 1.108 | 174 | 708 | 957 | 371 | 106.528 | 6.819 | 598 | 2.288 |
| Employees | 18 | 15 | 16 | 14 | 10 | 10 | 12 | 12 | 10 | 7 |
Check the financial reports for the company - Nexial Research S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 178.397 | 181.225 | 145.931 | 168.392 | 149.944 | 82.337 | 84.214 | 102.461 | 83.923 | 60.114 |
| Current Assets | 249.804 | 202.437 | 251.734 | 286.186 | 239.855 | 199.707 | 341.904 | 187.126 | 141.429 | 45.047 |
| Inventories | 45.328 | 16.434 | 5.145 | 71.566 | 71.855 | 71.125 | 10.476 | 10.756 | 14.578 | 14.750 |
| Receivables | 124.876 | 88.551 | 200.951 | 175.257 | 96.614 | 89.393 | 227.120 | 102.915 | 29.932 | 52.319 |
| Cash | 79.600 | 97.452 | 45.639 | 39.363 | 71.386 | 39.189 | 104.308 | 57.121 | 73.360 | -22.430 |
| Shareholders Funds | 350.444 | 294.535 | 289.725 | 284.660 | 280.056 | 231.650 | 332.866 | 230.170 | 153.712 | 23.711 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 83.905 | 96.636 | 113.192 | 174.041 | 114.199 | 54.925 | 97.880 | 67.989 | 80.280 | 89.617 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4741 - 4741" | |||||||||
| CAEN Financial Year |
4741
|
|||||||||
Comments - Nexial Research S.r.l.